Truist Financial Has Lowered Expectations for Aveanna Healthcare (NASDAQ:AVAH) Stock Price

Aveanna Healthcare (NASDAQ:AVAH) had its price target cut by Truist Financial from $6.00 to $5.50 in a research note issued to investors on Friday,Benzinga reports. They currently have a hold rating on the stock.

Separately, UBS Group boosted their price objective on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a research note on Friday, March 14th.

Aveanna Healthcare Stock Down 6.5 %

Shares of AVAH stock opened at $4.49 on Friday. The company has a market capitalization of $875.97 million, a P/E ratio of -13.21 and a beta of 1.99. Aveanna Healthcare has a 12-month low of $2.11 and a 12-month high of $6.19. The firm has a 50-day moving average price of $4.79 and a 200 day moving average price of $4.93.

Insider Buying and Selling

In related news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The stock was sold at an average price of $5.63, for a total value of $31,415.40. Following the transaction, the insider now owns 1,451,598 shares in the company, valued at $8,172,496.74. This trade represents a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold 67,412 shares of company stock worth $372,142 in the last quarter. Insiders own 7.80% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC raised its stake in shares of Aveanna Healthcare by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock worth $7,287,000 after buying an additional 63,190 shares during the last quarter. State Street Corp raised its position in shares of Aveanna Healthcare by 0.9% during the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company’s stock valued at $5,408,000 after acquiring an additional 9,446 shares during the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in shares of Aveanna Healthcare by 50.1% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company’s stock valued at $2,437,000 after purchasing an additional 177,856 shares during the period. Northern Trust Corp boosted its position in shares of Aveanna Healthcare by 11.3% in the 4th quarter. Northern Trust Corp now owns 478,907 shares of the company’s stock worth $2,189,000 after purchasing an additional 48,572 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Aveanna Healthcare by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 466,706 shares of the company’s stock worth $2,133,000 after purchasing an additional 4,047 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.